KRATOM CONSUMER PROTECTION
SB1183 creates the Kratom Consumer Protection Act, establishing a statewide regulatory framework for kratom leaf and kratom products in Illinois. The bill prohibits sale or distribution of kratom to anyone under 21, requires online age-verification for internet sales, and bars products that are attractive to children, adulterated with dangerous non-kratom substances, or contain synthesized or semi-synthesized kratom alkaloids or constituents. It also sets a product standard limiting 7-hydroxymitragynine content, and requires kratom products and processors to comply with federal manufacturing and FDA registration requirements.
The bill also imposes a 5% retail sales tax on kratom products, with quarterly reporting and Department of Revenue rulemaking and enforcement authority. It creates civil penalties for violations, escalating from up to $5,000 for a first violation to up to $10,000 for a second, and then to a mandatory minimum $10,000 fine and a three-year ban on selling kratom products in Illinois for third and subsequent violations. The measure repeals the existing Kratom Control Act and expressly preempts home rule units from regulating kratom manufacturing, packaging, labeling, distribution, or sale.
If enacted, SB1183 would replace the existing Kratom Control Act with a more detailed statewide regulatory and tax scheme for kratom. It would affect retailers, online marketplaces, manufacturers, processors, and distributors of kratom products by imposing age restrictions, product-composition limits, labeling and manufacturing compliance standards, reporting obligations, and significant civil and criminal penalties. It would also shift regulatory authority to the Illinois Department of Revenue for tax administration and enforcement, while limiting local government authority over kratom regulation.
Based on the bill text and the absence of committee testimony or recorded votes in the provided materials, the available record shows the bill as a policy proposal rather than a measure with documented debate or legislative sentiment. The structure of the bill suggests a consumer-protection approach that seeks to regulate rather than ban kratom, pairing public-health restrictions with tax collection and enforcement mechanisms. No formal support or opposition is reflected in the supplied context.
The main points of potential contention are likely to be the age restriction, the 5% excise tax, and the broad state preemption of local regulation. Retailers and kratom businesses may object to the tax burden, compliance costs, and severe penalties, while public-health advocates may focus on whether the product standards and child-attractiveness restrictions are sufficient. The prohibition on synthesized or semi-synthesized kratom compounds and the 7-hydroxymitragynine threshold may also be disputed by industry stakeholders over feasibility, testing, and product formulation.